Digital therapeutics company Theranica has received $45 million in its Series C funding round towards the commercial expansion of its drug-free migraine treatment, Nerivio, in the US.  Nerivio is a drug-free, smartphone-controlled wearable device for the treatment of episodic and chronic migraine in people aged 12 and older. Philadelphia-based New Rhein Healthcare Investors led the […]

The biomedical startup was the only Israeli firm on the list by CB Insights of 36 'high-momentum companies pioneering new ways to solve big problems.'

Theranica, founded in 2016, developed a wearable device for treating migraines through neuromodulation.

Are you an avid gum-chewer? Do you experience frequent headaches? If you answered "yes" to both questions, then chances are that the former causes the latter. A new Israeli study has shown that for young people with chronic headaches, giving up gum is the magic trick.